Anti-Tumor Necrosis Factor Therapies Reduce Serum Macrophage Inflammatory Protein-1? in Ankylosing Spondylitis
| dc.contributor.author | Akbulut, Handan | |
| dc.contributor.author | Koca, Suleyman S. | |
| dc.contributor.author | Ozgen, Metin | |
| dc.contributor.author | Isik, Ahmet | |
| dc.date.accessioned | 2026-08-12T17:30:26Z | |
| dc.date.issued | 2010 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.doi | 10.3899/jrheum.091469 | |
| dc.identifier.endpage | 1074 | |
| dc.identifier.issn | 0315-162X | |
| dc.identifier.issn | 1499-2752 | |
| dc.identifier.issue | 5 | |
| dc.identifier.orcid | 0000-0003-4995-430X | |
| dc.identifier.pmid | 20439531 | |
| dc.identifier.scopus | 2-s2.0-77951864537 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1073 | |
| dc.identifier.uri | https://doi.org/10.3899/jrheum.091469 | |
| dc.identifier.uri | https://hdl.handle.net/11508/56101 | |
| dc.identifier.volume | 37 | |
| dc.identifier.wos | WOS:000277696700046 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | J Rheumatol Publ Co | |
| dc.relation.ispartof | Journal of Rheumatology | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Rheumatoid-Arthritis | |
| dc.subject | Factor-Alpha | |
| dc.subject | Chemokine | |
| dc.subject | Cytokine | |
| dc.subject | Expression | |
| dc.subject | Joints | |
| dc.subject | Cells | |
| dc.title | Anti-Tumor Necrosis Factor Therapies Reduce Serum Macrophage Inflammatory Protein-1? in Ankylosing Spondylitis | |
| dc.type | Letter |







